Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rozman

Showing results (551-560 of 563) with videos related to

Pageof 57
Sort By:
Bone Marrow Transplantation|July 1, 1996
Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish GroupA Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|October 3, 1998
Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBTA Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|August 26, 1998
Allogeneic transplantation of purified CD34+ cells from peripheral blood: Spanish experience of 62 cases. Spanish Group of allo-PBTA Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|January 1, 1996
Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemiaC Rozman, E Carreras, C Qian, et al.
Blood|January 12, 2001
The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblingsA Urbano-Ispizua, C Rozman, P Pimentel, et al.
Medicina Clinica|May 10, 1997
[Hemopoietic progenitor cell transplantation: 20 years' experience at the Hematology School "Farreras-Valentí"/Clinical Hospital of Barcelona]C Rozman, E Carreras, J Sierra, et al.
Sangre|April 1, 1997
[Allogenic transplant of non-manipulated hematopoietic progenitor peripheral blood cells. Spanish experience of 79 cases. Allo-Peripheral Blood Transplantation Group]S Brunet, A Urbano-Ispizua, C Solano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow TransplantationJ Sierra, S Brunet, A Grañena, et al.
British Journal of Haematology|November 14, 1997
Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapyM J Zhang, M Baccarani, R P Gale, et al.
British Journal of Haematology|September 13, 2001
Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignanciesS Brunet, A Urbano-Ispizua, E Ojeda, et al.
Pageof 57

Showing results (551-560 of 563) with videos related to

Sort By:
Pageof 57
Bone Marrow Transplantation|July 1, 1996
Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish GroupA Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|October 3, 1998
Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBTA Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|August 26, 1998
Allogeneic transplantation of purified CD34+ cells from peripheral blood: Spanish experience of 62 cases. Spanish Group of allo-PBTA Urbano-Ispizua, C Solano, S Brunet, et al.
Bone Marrow Transplantation|January 1, 1996
Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemiaC Rozman, E Carreras, C Qian, et al.
Blood|January 12, 2001
The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblingsA Urbano-Ispizua, C Rozman, P Pimentel, et al.
Medicina Clinica|May 10, 1997
[Hemopoietic progenitor cell transplantation: 20 years' experience at the Hematology School "Farreras-Valentí"/Clinical Hospital of Barcelona]C Rozman, E Carreras, J Sierra, et al.
Sangre|April 1, 1997
[Allogenic transplant of non-manipulated hematopoietic progenitor peripheral blood cells. Spanish experience of 79 cases. Allo-Peripheral Blood Transplantation Group]S Brunet, A Urbano-Ispizua, C Solano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow TransplantationJ Sierra, S Brunet, A Grañena, et al.
British Journal of Haematology|November 14, 1997
Survival of patients with chronic myelogenous leukaemia relapsing after bone marrow transplantation: comparison with patients receiving conventional chemotherapyM J Zhang, M Baccarani, R P Gale, et al.
British Journal of Haematology|September 13, 2001
Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignanciesS Brunet, A Urbano-Ispizua, E Ojeda, et al.
Pageof 57